The application cycle for the fall 2022 program is now open.
Cancer is the second leading cause of death in the United States, claiming nearly 575,000 lives a year. Those deaths are the result of over 200 types of cancer, some of which remain only partially understood. But thanks to research, this gap between what we do and do not understand about cancer is shrinking.
We continue to take significant strides in how we treat cancer, and Drexel University College of Medicine is proud to contribute to that advancement by educating future researchers through our Cancer Biology (CBIO) program.
The Cancer Biology program is one of the most unusual programs in the country, as it offers students ability to work alongside 35 top cancer researchers in the Philadelphia area, including scientists from top cancer institutions including Drexel University, The Wistar Institute, Fox Chase Cancer Center and Lankenau Institute for Medical Research.
The program provides a master's degree focused on the fundamentals of cancer from an interdisciplinary perspective, including molecular and cell biology of cancer initiation, metastasis, immunology, treatment and prevention while gaining experience in cutting edge technology. Graduates of the program gain comprehensive knowledge of molecular, cell and cancer biology, as well as expertise in the latest techniques used in cancer biology research.
Is Cancer Biology for Me?
The Cancer Biology program is designed for students who wish to pursue a career in basic and applied cancer research, leading them to investigate the molecules, mechanisms, and pathways involved in the development of this disease.
Students in the program come from many backgrounds including:
- New college graduates
- Recent college graduates interested in career changes
- Laboratory technicians
- Industrial and biotechnology employees
News & Announcements
Congratulations to Pritika Shahani, MS candidate in our Cancer Biology program working in lab of Dr. Michael Bouchard, who will be starting a PhD program in at Medical University of South Carolina in Fall 2022.
Congratulations to Samuel Evans, MS candidate in our Cancer Biology program working in lab of Dr. Sri Somarowthu, who will be attending the PhD program in Genetics, Genomics, and Cancer Biology at Thomas Jefferson University in Fall 2022.
Alumni Publication in Oncogene
MS Cancer Biology graduates Jing Ju (2019) and Rebecca Moeller (2020) are co-authors on a recent publication entitled "O-GlcNAc transferase regulates glioblastoma acetate metabolism via regulation of CDK5-dependent ACSS2 phosphorylation" in the February 2022 issue of Oncogene. Jing and Rebecca performed their MS thesis research in lab of Dr. Mauricio Reginato.
Congratulations to the 2021 graduates of the Cancer Biology program: Marwah Al-Aloosi and Melissa Sutton-Navaro!
Student Publication in JoVE
Rebecca Moeller is a co-author on a recent publication entitled "An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth" in the September 2021 issue of the Journal of Visual Experimentation (JoVE). Rebecca performed her MS thesis research in lab of Dr. Mauricio Reginato.
Student Publication in Molecular Oncology
Shivani Sheth co-authored a publication, “FANCD2 limits acetaldehyde-induced genomic instability during DNA replication in esophageal keratinocytes,” in the July 2021 issue of Molecular Oncology. Shivani conducted her MS thesis research in the lab of Dr. Eishi Noguchi.
Recent Thesis Defenses
Melissa Sutton-Navarro, MS
May 2021, Non-Thesis review title: “Targeting epigenetic vulnerabilities in high-grade serous ovarian cancer”
Advisor: Dr. Todd Strochlic
Marwa Al-Aloosi, MS, MD
May 2021, Non-Thesis review title: “Clinical review of hepatocellular carcinoma”
Advisor: Dr. Michael Bouchard
In the Media
"Teaming Up to Fight Brain Tumors"
College of Medicine Alumni Magazine (Fall/Winter 2016)